Drug Enforcement Administration June 2018 – Federal Register Recent Federal Regulation Documents

Decision and Order: Mohammed Asgar, M.D.
Document Number: 2018-13531
Type: Notice
Date: 2018-06-25
Agency: Drug Enforcement Administration, Department of Justice
Decision and Order: Kevin G. Morgan, RN/APN
Document Number: 2018-13530
Type: Notice
Date: 2018-06-25
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Unither Manufacturing LLC
Document Number: 2018-13410
Type: Notice
Date: 2018-06-22
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: American Radiolabeled Chem
Document Number: 2018-13231
Type: Notice
Date: 2018-06-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2018-13224
Type: Notice
Date: 2018-06-20
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Registration
Document Number: 2018-13223
Type: Notice
Date: 2018-06-20
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of schedule I and II controlled substances.
Bulk Manufacturer of Controlled Substances Application: Cerilliant Corporation
Document Number: 2018-13221
Type: Notice
Date: 2018-06-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2018-12884
Type: Notice
Date: 2018-06-15
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Gazelle A. Craig, D.O.; Decision and Order
Document Number: 2018-12686
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Johnson Matthey Pharmaceutical Materials Inc.
Document Number: 2018-12685
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Bulk Manufacturer of Controlled Substances Application: Alcami Wisconsin Corporation
Document Number: 2018-12684
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Cambrex Charles City
Document Number: 2018-12683
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Bellwyck Clinical Services
Document Number: 2018-12682
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Restek Corporation
Document Number: 2018-12680
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Registration
Document Number: 2018-12670
Type: Notice
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
Registrants listed below have applied for and been granted registration by-the Drug Enforcement Administration (DEA) as importers of various classes of schedule I or II controlled substances.
Schedules of Controlled Substances: Temporary Placement of N-Ethylpentylone in Schedule I
Document Number: 2018-12669
Type: Proposed Rule
Date: 2018-06-13
Agency: Drug Enforcement Administration, Department of Justice
The Acting Administrator of the Drug Enforcement Administration is publishing this notice of intent to issue an order temporarily scheduling N-1-(1,3-benzodioxol-5-yl)-2-(ethylamino)-1- pentanone (N-ethylpentylone, ephylone) in schedule I. This action is based on a finding by the Acting Administrator that the placement of N- ethylpentylone in schedule I is necessary to avoid an imminent hazard to the public safety. When it is issued, the temporary scheduling order will impose regulatory requirements under the Controlled Substances Act (CSA) on the manufacture, distribution, reverse distribution, possession, importation, exportation, research, and conduct of instructional activities, and chemical analysis of N-ethylpentylone, as well as administrative, civil, and criminal remedies with respect to persons who fail to comply with such requirements or otherwise violate the CSA with respect to N-ethylpentylone.
Richard Hauser, M.D.; Decision and Order
Document Number: 2018-12138
Type: Notice
Date: 2018-06-06
Agency: Drug Enforcement Administration, Department of Justice